March 18, 2020 / 10:42 AM / in 23 days

BRIEF-Springworks Therapeutics Announces Issuance Of New U.S. Composition Of Matter Patent To Polymorphic Form Of Nirogacestat

March 18 (Reuters) - Springworks Therapeutics Inc:

* SPRINGWORKS THERAPEUTICS ANNOUNCES ISSUANCE OF NEW U.S. COMPOSITION OF MATTER PATENT TO POLYMORPHIC FORM OF NIROGACESTAT, EXTENDING PATENT PROTECTION INTO 2039 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below